Anti-endothelial cell antibodies (AECA) are demonstrated in connective tissue diseases
(CTD) such as systemic lupus erythematosus (SLE) and progressive systemic sclerosis …

Using unfixed cultured endothelial cells isolated from human umbilical veins, we performed
cellular enzyme-linked immunosorbent assay (ELISA) for the detection of anti-endothelial …

To investigate the prevalence and possible role of anti-endothelial cell antibodies (AECA) in
the pathogenesis of systemic lupus erythematosus (SLE), cell membrane antigen was …

Anti-endothelial cell antibodies (AECA) have been detected in autoimmune diseases such
as systemic lupus erythematosus (SLE) and scleroderma (PSS) but their role in …

Anti-endothelial antibodies (AEA) have been described in patients with rheumatoid arthritis
(RA) complicated by vasculitis. In this study we made use of an ELISA and immunoblot …

IgG anti‐endothelial antibodies (AEA), as measured by EL1SA or immunoblotting technique
could be delected in serum samples or 56 out of 64 patients with SLE (88%) and mainly …

IgG anti–endothelial cell antibodies (AECA) were detected in 48.5% of patients with active
systemic lupus erythematosus (SLE) and in 7% of patients during remission and were …

Objective Antiendothelial cell antibodies (aECA) have been demonstrated in patients with
systemic lupus erythematosus (SLE), but their role in the pathogenesis of this disease …

Anti-endothelial-cell antibodies (AECAs) were first described in the serum of patients with
systemic lupus erythcmatosus(SLE) almost 25 years ago'**, and have been subsequently …

Purpose It was confirmed experimentally that antiendothelial cell antibodies (AECA) react
directly with the vascular endothelium and are involved in the pathogenesis of vasculitis …